Erasca, Inc. is a clinical-stage precision oncology company committed to eradicating cancer by targeting one of cancer's most commonly mutated pathways, the RAS/MAPK pathway. The company is dedicated to developing a modality-agnostic portfolio of therapeutic programs designed to thoroughly shut down the RAS/MAPK pathway, which affects millions of lives globally each year. Erasca is advancing a robust pipeline with the potential to transform cancer treatment and improve the lives of patients suffering from various types of cancer. With a focus on groundbreaking science in oncology, Erasca aims to bring new hope to patients and lead the way in precision oncology innovations.
51 - 200 employees
Founded 2020
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $100M Post-IPO Equity on 2022-12
March 19
Lead safety operations at Erasca, ensuring compliance and efficiency in pharmacovigilance processes. Collaborate with global teams on clinical trials and vendor oversight.
π California β Remote
π΅ $175k - $202.5k / year
π° $100M Post-IPO Equity on 2022-12
β° Full Time
π Senior
βοΈ Operations
Remote Jobs at Erasca, Inc.